A systematic review of models of patient engagement in the development and life cycle management of medicines

F. I. Auwal*, C. Copeland, E. J. Clark, C. Naraynassamy, G. R. McClelland

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Abstract

There is currently no universally agreed code of practice for patient engagement (PE), and existing guidelines do not fully cover the scope across medicine development and subsequent life cycle management. This review conceptualises the meaning and summarises the current models of PE. A systematic literature review was conducted and analysed by thematic synthesis. Eight themes were identified as components of how to achieve meaningful PE, and five were identified for where to engage with patients in drug development. This review provides summative guidance for stakeholders intending to introduce PE and establishes a starting point for the development of a universal code of practice.

Original languageEnglish
Article number103702
JournalDRUG DISCOVERY TODAY
Volume28
Issue number9
Early online date13 Jul 2023
DOIs
Publication statusPublished - Sept 2023

Keywords

  • guidance
  • medicines development
  • models
  • patient engagement
  • research and development
  • roadmap

Fingerprint

Dive into the research topics of 'A systematic review of models of patient engagement in the development and life cycle management of medicines'. Together they form a unique fingerprint.

Cite this